FDA Cardiovascular Indication Expansion and Dispensing of Semaglutide/Tirzepatide in CVD Patients With Overweight/ObesityDzuy Do, Nicholas L. Stucky, Brianna M. Goodwin Cartwright et al.|JACC Advances|2026Cited by 0